A multicenter, randomized, open-label, parallel design trial to compare time to response in the symptoms of anxiety to concomitant treatment with Niravam [alprazolam] and an SSRI [selective serotonin reuptake inhibitor] or SNRI [selective norepinephrine reuptake inhibitor] to treatment with an SSRI or SNRI alone in subjects with generalized anxiety disorder or panic disorder.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Alprazolam (Primary) ; Adrenergic receptor antagonists; Serotonin uptake inhibitors
- Indications Generalised anxiety disorder; Panic disorder
- Focus Therapeutic Use
- Sponsors UCB
- 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Sep 2006 New trial record.